Thomas Bjarnsholt

Thomas Bjarnsholt

Professor


  1. Published

    Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms

    Alhede, M., Alhede, M. & Bjarnsholt, Thomas, 1 Jan 2014, Antibiofilm Agents. Rumbaugh, K. (ed.). Springer Publishing Company, Vol. 8. p. 257-272 16 p. (Springer Series on Biofilms, Vol. 8).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  2. Published
  3. Published

    Treatment of implant-associated osteomyelitis with injectable in situ-forming depot drug delivery system

    Fuglsang-Madsen, A., Henriksen, Nicole Lind, Kvich, Lasse Andersson, Birch, Julie Knippel Melsted, Hartmann, Katrine Top, Bjarnsholt, Thomas, Andresen, T. L., Jensen, Louise Kruse, Henriksen, J. R. & Hansen, A. E., 2022.

    Research output: Contribution to conferenceConference abstract for conferenceCommunication

  4. Published

    Delayed neutrophil recruitment to the tissue-implant-interface is seen within the first hours following insertion of a contaminated abiotic implant in mice

    Hansen, Marie Høy, Stewart, P. S., Borgogna, T., Bjarnsholt, Thomas & Jensen, Louise Kruse, 26 Jun 2024.

    Research output: Contribution to conferenceConference abstract for conferenceCommunication

  5. Published

    Extensive debridement is fundamental for the success of an absorbable gentamicin loaded bio-composite

    Jensen, Louise Kruse, Blirup-Plum, Sophie Amalie, Aalbæk, Bent, Bjarnsholt, Thomas, Kragh, K. N., Gottlieb, H., Bue, M. & Jensen, Henrik Elvang, 12 Sep 2019.

    Research output: Contribution to conferenceConference abstract for conferenceCommunication

  6. Published

    Extreme high local intra-operative gentamicin concentrations are needed to prevent biofilm formation in-vivo

    Jensen, Louise Kruse, Bjarnsholt, Thomas, Henriksen, Nicole Lind, Kragh, K. N. & Jensen, Henrik Elvang, 6 Sep 2018.

    Research output: Contribution to conferenceConference abstract for conferenceCommunication

ID: 9755066